---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-008170"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:13:51.940184+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences receives Nasdaq extension to May 29, 2023 to regain $1 bid price compliance

## Summary
- Nasdaq granted an additional 180 calendar days, until May 29, 2023, to meet the $1.00 minimum bid price requirement.
- Company previously notified of non-compliance on June 3, 2022; bid price below $1.00 for 30 consecutive business days.
- Eligibility based on meeting all other initial listing standards and written intent to cure via reverse stock split if needed.
- If bid price closes at $1.00+ for 10 consecutive days before May 29, 2023, compliance will be achieved.
- Failure to cure may lead to delisting, subject to appeal to a Nasdaq hearings panel.

## SEC filing metadata
- accession: 0001683168-22-008170
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008170/0001683168-22-008170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008170/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-008170
- JSON: https://secwatch.observer/filing/0001683168-22-008170.json
- Plain text: https://secwatch.observer/filing/0001683168-22-008170.txt

## Key facts
- Listing & Compliance Notices
  Xenetic Biosciences, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: December 1, 2022, the Company received a letter from Nasdaq informing it that although the Company’s common stock has not regained compliance with the minimum $1.00 bid price per share requirement, Nasdaq has determined that the Company is eligible for an additional 180 calendar day period, or until May 29, 2023, to regain compliance. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requireme
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316822008170/0001683168-22-008170-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.